Prophylactic hemodialysis following coronary angiography and one-year outcomes in non-dialysis patients with chronic kidney disease: A propensity-matched study

Chen, Hsin Yu; Ou, Shih Hsiang; Chou, Kang Ju; Fang, Hua; Chen, Chien Liang; Hsu, Chih Yang; Huang, Chien‐Wei; Chang, Chung Chou H.; Lee, Po‐Tsang; Yang, Chia-Ming

doi:10.1016/j.jfma.2020.07.020

Cited by 1 publication

(2 citation statements)

References 53 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 25 , 26 Only 3 studies showed the association between decreasing 1-year mortality rate and prophylactic RRT. 24 - 26 While the study by Hsieh et al 23 showed no significant benefit of prophylactic RRT in 1-year mortality. The pooled analysis revealed a non-significant decreased risk of 1-year mortality in CKD patients who underwent coronary angiography and prophylactic RRT compared to those who did not have prophylactic RRT (RR = 0.59; P = .…”

Section: Resultsmentioning

confidence: 96%

“…Five studies were included in this meta-analysis, involving 532 CKD patients who underwent coronary angiography (268 had prophylactic RRT, and 264 did not have prophylactic RRT). Prophylactic RRT in 3 out of 5 studies was HD, 22 - 24 and the other 2 studies were hemofiltration. 25 , 26 Only 3 studies showed the association between decreasing 1-year mortality rate and prophylactic RRT.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Meta-Analysis of Prophylactic Renal Replacement Therapy after Cardiac Catheterization in Patients with Chronic Kidney Disease

Temtanakitpaisan

2023

Anatol J Cardiol

View full text Add to dashboard Cite

Background: The benefits of prophylactic renal replacement therapy after cardiac catheterization in patients with chronic kidney disease remain unclear. The aim of this study is to confirm the benefit of prophylactic renal replacement therapy after cardiac catheterization. Methods: We systematically searched for studies published from inception to December 2022 examining the benefits of prophylactic renal replacement therapy after cardiac catheterization in MEDLINE and EMBASE. Data analysis was performed according to the PRISMA statement using the Mantel–Haenszel method. Results: Five studies met the inclusion criteria, which comprised of 532 chronic kidney disease patients who underwent coronary angiography (268 had prophylactic renal replacement therapy and 264 did not have prophylactic renal replacement therapy). The pooled analysis revealed a non-significant decreased risk of 1-year mortality in chronic kidney disease patients who underwent coronary angiography and prophylactic renal replacement therapy compared to those who did not have prophylactic renal replacement therapy (RR = 0.59; P = . 18; CI: 0.28-1.2795, I 2 = 60.4%). The risk of hemodialysis during hospitalization and renal replacement therapy requirement in 1 year in chronic kidney disease patients who underwent coronary angiography and prophylactic renal replacement therapy were lower than in those who did not have prophylactic renal replacement therapy (RR = 0.13; P = . 001; CI: 0.04-0.43, I 2 = 9.1% and RR = 0.29; P = . 015; CI: 0.11-0.78, I 2 = 49.9%, respectively). The sensitivity analysis demonstrated that the overall findings remained consistent and did not significantly alter. Conclusions: Prophylactic renal replacement therapy did not seem to lower 1-year mortality among chronic kidney disease patients who underwent coronary angiography. However, prophylactic renal replacement therapy appeared to reduce the risk of hemodialysis during hospitalization and renal replacement therapy requirement in 1 year.

show abstract